Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Martina Burlando"'
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2645-2652 (2024)
Abstract Introduction The efficacy and safety of tildrakizumab for the treatment of plaque psoriasis were demonstrated by randomized clinical studies, but the reappraisal of prolonged experiences in the clinical practice helps to optimize the use of
Externí odkaz:
https://doaj.org/article/b428056128db4741bbf3c2c6950d88a8
Autor:
Luigi Gargiulo, Luciano Ibba, Alessandra Narcisi, Silvia Giordano, Carlo A. Maronese, Fabrizio Martora, Federica Repetto, Giovanni Paolino, Anna Balato, Martina Burlando, Paolo Dapavo, Valentina Dini, Claudio Guarneri, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Antonio Costanzo, Mario Valenti
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 4 (2024)
Introduction: Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory diseases with significant overlap in their immunologic pathways, which involve cytokines such as tumor necrosis factor-alfa, interleukin (IL)-17, and IL-23. Current tr
Externí odkaz:
https://doaj.org/article/8bd8149f86274025acc4efd6ef6b99f0
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 4 (2024)
Introduction: Approximately half of patients affected by psoriasis are women, and the management of female patients of childbearing age is an under-investigated topic. Some studies have shown a significant decrease in births in psoriatic patients, du
Externí odkaz:
https://doaj.org/article/80669a056d70418ea605d34bdae179f8
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/7d26cfef736148cb8d21e50168898a29
Autor:
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G. Carrera, Paolo Dapavo, Valentina Dini, Francesca M. Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 6, Pp 1649-1657 (2024)
Abstract Introduction The introduction of biological therapies has revolutionized the treatment of moderate-to-severe plaque psoriasis. In particular, ixekizumab, an inhibitor of interleukin-17A, has shown great results in terms of efficacy and safet
Externí odkaz:
https://doaj.org/article/2457ce851f3b4d589b890cf51ca53d3c
Autor:
Sarah Alulis, Nicoletta Bernardini, Martina Burlando, Antonio Costanzo, Pier Cesare Francesa Morel, Paolo Gisondi, Francesco Loconsole, Matteo Megna, Giovanni Pellacani, Stefano Piaserico, Francesca Prignano, Ottavio Secchi, Nevena Skroza, Fareen Hassan
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1273-1291 (2024)
Abstract Introduction There are several treatment options for plaque psoriasis (PsO), but uncertainty remains around the optimal sequencing of treatments. The aims of this study were to investigate how adopting a best-treatment-first treatment sequen
Externí odkaz:
https://doaj.org/article/ff75665eae034ad7a5181488eb2829bc
Autor:
Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Pina Brianti, Giovanna Brunasso, Martina Burlando, Anna E. Cagni, Marzia Caproni, Carlo G. Carrera, Andrea Carugno, Francesco Caudullo, Aldo Cuccia, Paolo Dapavo, Eugenia V. Di Brizzi, Valentina Dini, Francesca M. Gaiani, Paolo Gisondi, Claudio Guarneri, Claudia Lasagni, Gaetano Licata, Francesco Loconsole, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Maria L. Musumeci, Diego Orsini, Simone Ribero, Valentina Ruffo Di Calabria, Francesca Satolli, Davide Strippoli, Massimo Travaglini, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractPurpose Tildrakizumab is a selective inhibitor of IL-23 approved for the treatment of moderate-to-severe plaque psoriasis in two dosages. We conducted a 16-week multicenter retrospective study to compare the effectiveness and safety of tildra
Externí odkaz:
https://doaj.org/article/50011e4f4d42477e96cf16f9d602b59b
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Immune-mediated comorbidities in patients with psoriasiform eczema are common. It can be challenging to manage multiple immune-mediated diseases, especially considering that biologic treatments are prone to causing paradoxical effects. The aim of thi
Externí odkaz:
https://doaj.org/article/b8d3eba042304c269aa6ee5c36f3ec8a
Autor:
Anna Balato, Francesca Ambrogio, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Maria Esposito, Stefano Piaserico, Miriam Teoli, Paolo Gisondi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 1, Pp 5-13 (2023)
Externí odkaz:
https://doaj.org/article/47d2afcf1e714ff893cbd91f46ffd377
Autor:
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, Alessandro Giunta, Giuseppe Argenziano, Chiara Assorgi, Anna Balato, Nicoletta Bernardini, Alexandra Maria Giovanna Brunasso, Martina Burlando, Giacomo Caldarola, Anna Campanati, Andrea Carugno, Franco Castelli, Andrea Conti, Antonio Costanzo, Aldo Cuccia, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Vito Di Lernia, Valentina Dini, Massimo Donini, Enzo Errichetti, Maria Esposito, Maria Concetta Fargnoli, Antonio Foti, Carmen Fiorella, Luigi Gargiulo, Paolo Gisondi, Claudio Guarneri, Agostina Legori, Serena Lembo, Francesco Loconsole, Piergiorigio Malagoli, Angelo Valerio Marzano, Santo Raffaele Mercuri, Matteo Megna, Giuseppe Micali, Edoardo Mortato, Maria Letizia Musumeci, Alessandra Narcisi, Anna Maria Offidani, Diego Orsini, Giovanni Paolino, Giovanni Pellacani, Ketty Peris, Concetta Potenza, Francesca Prignano, Pietro Quaglino, Simone Ribero, Antonio Giovanni Richetta, Marco Romanelli, Antonio Rossi, Davide Strippoli, Emanuele Trovato, Marina Venturini, Luca Bianchi
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1378 (2024)
(1) Background/Objectives: Nail psoriasis (NP) is a chronic and difficult-to-treat disease, which causes significant social stigma and impairs the patients’ quality of life. Moreover, nail psoriasis is a true therapeutic challenge for clinicians. T
Externí odkaz:
https://doaj.org/article/de7ced820b9f497b8c4d8350be2e627f